Skip to main content

Table 1 Characteristics of participants with HCV Core-E1 sequences in the ALIVE cohort

From: Factors associated with phylogenetic clustering of hepatitis C among people who inject drugs in Baltimore

Characteristic Total (%)
(n = 508)
Age, years (median [IQR]) 53.9 (46.8–59.3)
Black race 441 (86.8)
Male sex 345 (67.9)
Female sex 163 (32.1)
High school education or higher 202 (39.8)
Homelessnessa 98 (19.3)
Incarcerated ≥1 weeka 51 (10.1)
HCV Genotype
 1a 421 (82.9)
 1b 87 (17.1)
HIV positive at baseline 167 (32.9)
HIV seroconverted (baseline to most recent visit) 29 (5.7)
HIV positive at most recent visit 196 (38.6)
Most recent HIV RNA among HIV infectedb
 HIV RNA < 400 copies/ml 111 (56.6)
 HIV RNA ≥ 400 copies/ml 51 (26.0)
Prescribed methadone or buprenorphine 176 (34.7)
Injection drug use behaviors
 Years injecting (mean [SD]) 12.68 (10.8)
 Ever shared a syringe at baseline 451 (89.1)
 Injected drugsa 204 (40.2)
 Shared syringea 85 (16.7)
 Used cracka 157 (31.0)
 Injected or snorted cocainea 112 (22.1)
 Injected heroina 146 (28.7)
 Snorted heroina 85 (16.7)
 Injected speedballa 122 (24.0)
 Visited SSP in the last month 61 (12.1)
  1. aWithin 6 months of visit
  2. bHIV RNA unavailable in 34 HIV infected patients
  3. HCV hepatitis c virus, SSP syringe service program, HIV human immunodeficiency virus, RNA ribonucleic acid, IQR interquartile range, SD standard deviation